Coca Cola Femsa (NYSE:KOF) vs. Arcadia Biosciences (NASDAQ:RKDA) Critical Contrast

Arcadia Biosciences (NASDAQ:RKDA) and Coca Cola Femsa (NYSE:KOF) are both consumer staples companies, but which is the better stock? We will contrast the two businesses based on the strength of their earnings, profitability, risk, analyst recommendations, valuation, institutional ownership and dividends.

Institutional and Insider Ownership

17.7% of Arcadia Biosciences shares are owned by institutional investors. 4.5% of Arcadia Biosciences shares are owned by company insiders. Comparatively, 1.0% of Coca Cola Femsa shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Volatility and Risk

Arcadia Biosciences has a beta of 0.53, meaning that its share price is 47% less volatile than the S&P 500. Comparatively, Coca Cola Femsa has a beta of 0.52, meaning that its share price is 48% less volatile than the S&P 500.

Profitability

This table compares Arcadia Biosciences and Coca Cola Femsa’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Arcadia Biosciences	-234.53%	-183.50%	-91.25%
Coca Cola Femsa	8.05%	15.83%	7.32%

Analyst Ratings

This is a summary of current ratings for Arcadia Biosciences and Coca Cola Femsa, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Arcadia Biosciences	1	0	0	0	1.00
Coca Cola Femsa	0	5	4	0	2.44

Coca Cola Femsa has a consensus price target of $118.83, indicating a potential upside of 8.02%. Given Coca Cola Femsa’s stronger consensus rating and higher possible upside, analysts clearly believe Coca Cola Femsa is more favorable than Arcadia Biosciences.

Valuation and Earnings

This table compares Arcadia Biosciences and Coca Cola Femsa”s revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Arcadia Biosciences	$4.86 million	0.23	-$2.34 million	($4.56)	-0.10
Coca Cola Femsa	$15.22 billion	12.15	$1.32 billion	$6.34	17.35

Coca Cola Femsa has higher revenue and earnings than Arcadia Biosciences. Arcadia Biosciences is trading at a lower price-to-earnings ratio than Coca Cola Femsa, indicating that it is currently the more affordable of the two stocks.

Summary

Coca Cola Femsa beats Arcadia Biosciences on 11 of the 14 factors compared between the two stocks.

About Arcadia Biosciences

Arcadia Biosciences, Inc. produces and markets plant-based food and beverage products in the United States. The company develops crop improvements primarily in wheat to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients. Its food, beverage, and body case products include GoodWheat, Zola coconut water, ProVault topical pain relief, and SoulSpring. The company was incorporated in 2002 and is headquartered in Dallas, Texas.

About Coca Cola Femsa

Coca-Cola FEMSA, S.A.B. de C.V., a franchise bottler, produces, markets, sells, and distributes Coca-Cola trademark beverages in Mexico, Guatemala, Nicaragua, Costa Rica, Panama, Colombia, Brazil, Argentina, and Uruguay. The company offers sparkling beverages, including colas and flavored sparkling beverages; waters; other non-carbonated beverages comprising juice drinks, coffee, teas, milk, value-added dairy products, sports and energy drinks, and plant-based drinks; and alcoholic beverages, such as hard seltzer under the Topo Chico brand name. It also distributes and sells Heineken, Estrella Galicia, Therezópolis, and Campari beer products, as well as Perfetti confectionary and chewing gum in its Brazilian territories; and Monster products. The company sells its products to distributors, retail outlets, wholesale supermarkets, discount and convenience stores, retailers, points-of-sale outlets, restaurants, bars, stadiums, auditoriums, theaters, and home deliveries. Coca-Cola FEMSA, S.A.B. de C.V. was founded in 1979 and is headquartered in Mexico City, Mexico.